纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-12-31 | GILD | 吉利德科学 | 603.23 | 8.01% |
| 2022-12-31 | AMGN | 安进 | 565.95 | 7.51% |
| 2022-12-31 | REGN | 再生元制药 | 546.71 | 7.26% |
| 2022-12-31 | VRTX | 福泰制药 | 524.33 | 6.96% |
| 2022-12-31 | MRNA | Moderna Inc | 488.01 | 6.48% |
| 2022-12-31 | AZN | 阿斯利康(US ADR) | 293.09 | 3.89% |
| 2022-12-31 | BIIB | 生化基因 | 280.04 | 3.72% |
| 2022-12-31 | ILMN | Illumina Inc | 225.04 | 2.99% |
| 2022-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 206.89 | 2.75% |
| 2022-12-31 | HZNP | Horizon Therapeutics plc | 182.45 | 2.42% |
| 2022-12-31 | SGEN | Seagen Inc | 168.8 | 2.24% |
| 2022-12-31 | BMRN | 拜玛林制药 | 136.08 | 1.81% |
| 2022-12-31 | INCY | 因塞特医疗 | 126.42 | 1.68% |
| 2022-12-31 | RPRX | Royalty Pharma plc-A | 123.34 | 1.64% |
| 2022-12-31 | SNY | 赛诺菲 | 99 | 1.31% |
| 2022-12-31 | BNTX | BioNTech SE ADR | 97.72 | 1.3% |
| 2022-12-31 | VTRS | Viatris Inc | 95.5 | 1.27% |
| 2022-12-31 | UTHR | 联合治疗 | 89.67 | 1.19% |
| 2022-12-31 | ARGX | argenx SE ADR | 83.37 | 1.11% |
| 2022-12-31 | NBIX | 神经分泌生物科学 | 81.27 | 1.08% |
公告&资料
